MCCALL JEWETT: Open Payments
NPI 1841970662 · SALEM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 20 payments from 8 companies in 2025. Trend: 2023 $100 · 2024 $328 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $138 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $31 |
| SANOFI PASTEUR INC. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 2 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Ardelyx, Inc. | 1 | $15 |
Products named: UBRELVY, Auvelity, QULIPTA, BEYFORTUS, VRAYLAR, INGREZZA, Sunosi, VOQUEZNA.
Industry payments across UT — which companies pay providers there.
